Topical treatment for vaginal candidiasis (thrush) in pregnancy

Young, Gavin; Jewell, David

doi:10.1002/14651858.cd000225

Cited by 63 publications

(58 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therapy of RVVC in pregnant women can be local, which has no proven teratogenic effect 157,158 . However, there is some evidence that clotrimazole therapy during pregnancy might be associated with undescended testes in offspring 157 .…”

Section: Side Effects Of Antifungal Drugsmentioning

confidence: 99%

Facts and myths on recurrent vulvovaginal candidosis—a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy

Rodrigues²,

et al. 2002

View full text Add to dashboard Cite

Summary:Approximately three-quarters of all women will experience an episode of vulvovaginal candidosis at least once in their life and 5± 10% of them will have more than one attack. Women suffering from three to four attacks within 12 months will be diagnosed with recurrent vulvovaginal candidosis (RVVC). This review covers the large number of proposed aetiological factors for RVVC. The diagnosis of the condition made by conventional means by health providers is often false and is also often misdiagnosed by the affected woman herself. The review covers various methods of diagnosing RVVC and the current knowledge on potential pathogenetic mechanisms proposed for genital candida infections. Treatment of RVVC, including local and systemic antimicrobial therapy and behaviour modi® cation to decrease the risk of recurrences, are discussed. Recent knowledge on drug resistance in candida is also included.

show abstract

Section: Side Effects Of Antifungal Drugsmentioning

confidence: 99%

Facts and myths on recurrent vulvovaginal candidosis—a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy

Rodrigues²,

et al. 2002

View full text Add to dashboard Cite

show abstract

“…Systemic absorption of these topical medications is minimal, posing little risk of transfer to the fetus [7]. Azole therapy during pregnancy should be recommended for 7 days instead of a shorter duration of therapy because of improved treatment success [8].…”

Section: Introductionmentioning

confidence: 99%

Bee-honey and yogurt: a novel mixture for treating patients with vulvovaginal candidiasis during pregnancy

Abdelmonem

Rasheed

Mohamed

2012

Arch Gynecol Obstet

View full text Add to dashboard Cite

show abstract

“…Two previous reviews 22,23 have evaluated the effectiveness of anti-fungal drugs. The systematic review of topical antifungal drugs for the treatment of candidiasis in pregnancy showed that topical imidazoles were more effective than nystatin 22 . The same review showed that single dose therapy was less effective than three to four days of treatment and that seven days anti-fungal treatment was more effective than four days treatment.…”

Section: Discussionmentioning

confidence: 99%

Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review

Watson

2002

BJOG: An International Journal of Obstetrics and Gynaecology

View full text Add to dashboard Cite

Objectives To compare the relative effectiveness, cost effectiveness and safety of oral versus intra-vaginal anti-fungal treatments for uncomplicated vulvovaginal candidiasis (thrush) and establish patient preference for the route of anti-fungal administration. . The reference list of each trial was checked for additional references. The manufacturers of anti-fungal treatments in the UK were asked for information on trials fulfilling the inclusion criteria. Methods There was duplicate, independent examination and selection of the electronic search results followed by duplicate data abstraction. Disagreements regarding inclusion status and data abstraction were resolved by discussion between reviewers and the editor of the Cochrane Sexually Transmitted Disease group. Randomised controlled trials conducted worldwide and published in any language were included. The primary outcome measure was clinical cure. Mycological cure, patient preference and safety were secondary outcome measures.

show abstract

Topical treatment for vaginal candidiasis (thrush) in pregnancy

Cited by 63 publications

References 14 publications

Facts and myths on recurrent vulvovaginal candidosis—a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy

Facts and myths on recurrent vulvovaginal candidosis—a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy

Bee-honey and yogurt: a novel mixture for treating patients with vulvovaginal candidiasis during pregnancy

Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review

Contact Info

Product

Resources

About